articles2020-07-28T11:39:10+00:00

PUBLICATIONS

Articles

MCDA Hemlibra® in haemophilia A without inhibitors

May 18th, 2020|

Determining the value contribution of emicizumab (hemlibra®) for the prophylaxis of haemophilia A patients without inhibitors in Spain by multi-criteria decision analysis (MCDA) Avalia [...]

MCDA inhaler device in COPD treatment

May 14th, 2020|

Is patients’ perspective incorporated when choosing an inhaler device for COPD treatment? A framework value assessment based in Multi Criteria Decision Analysis Avaliable at: https://e [...]

MCDA framework for Oncologic Treatments

March 11th, 2020|

Development of a Multicriteria Decision Analysis Framework for Evaluating and Positioning Oncologic Treatments in Clinical Practice Avaliable at: https://ascopubs.org/doi/abs/10.1200/J [...]

MCDA Hemlibra® in haemophilia A with inhibitors

October 8th, 2019|

Determining the value contribution of emicizumab (Hemlibra®) for the prophylaxis of haemophilia A with inhibitors in Spain by multi-criteria decision analysis Avaliable at: https://jou [...]

MCDA framework for Ophan Drugs in Spain

August 8th, 2019|

Development and validation of an MCDA framework for evaluation and decision-making of orphan drugs in Spain Avaliable at: https://www.tandfonline.com/doi/abs/10.1080/21678707.2019.1652 [...]

Load More Posts